Literature DB >> 11160675

In vitro and in vivo infectivity and pathogenicity of the lymphoid cell-derived woodchuck hepatitis virus.

Y Y Lew1, T I Michalak.   

Abstract

Woodchuck hepatitis virus (WHV) and human hepatitis B virus are closely related, highly hepatotropic mammalian DNA viruses that also replicate in the lymphatic system. The infectivity and pathogenicity of hepadnaviruses propagating in lymphoid cells are under debate. In this study, hepato- and lymphotropism of WHV produced by naturally infected lymphoid cells was examined in specifically established woodchuck hepatocyte and lymphoid cell cultures and coculture systems, and virus pathogenicity was tested in susceptible animals. Applying PCR-based assays discriminating between the total pool of WHV genomes and covalently closed circular DNA (cccDNA), combined with enzymatic elimination of extracellular viral sequences potentially associated with the cell surface, our study documents that virus replicating in woodchuck lymphoid cells is infectious to homologous hepatocytes and lymphoid cells in vitro. The productive replication of WHV from lymphoid cells in cultured hepatocytes was evidenced by the appearance of virus-specific DNA, cccDNA, and antigens, transmissibility of the virus through multiple passages in hepatocyte cultures, and the ability of the passaged virus to infect virus-naive animals. The data also revealed that WHV from lymphoid cells can initiate classical acute viral hepatitis in susceptible animals, albeit small quantities (approximately 10(3) virions) caused immunovirologically undetectable (occult) WHV infection that engaged the lymphatic system but not the liver. Our results provide direct in vitro and in vivo evidence that lymphoid cells in the infected host support propagation of infectious hepadnavirus that has the potential to induce hepatitis. They also emphasize a principal role of the lymphatic system in the maintenance and dissemination of hepadnavirus infection, particularly when infection is induced by low virus doses.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11160675      PMCID: PMC114086          DOI: 10.1128/JVI.75.4.1770-1782.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  40 in total

1.  G1 phase dependent nuclear localization of relaxed-circular hepatitis B virus DNA and aphidicolin-induced accumulation of covalently closed circular DNA.

Authors:  C T Yeh; H T Chiu; C M Chu; Y F Liaw
Journal:  J Med Virol       Date:  1998-05       Impact factor: 2.327

2.  In vitro model for the nuclear transport of the hepadnavirus genome.

Authors:  M Kann; A Bischof; W H Gerlich
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

3.  Transcription of hepatitis B virus in peripheral blood mononuclear cells from persistently infected patients.

Authors:  S Stoll-Becker; R Repp; D Glebe; S Schaefer; J Kreuder; M Kann; F Lampert; W H Gerlich
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

4.  n-Butyrate, a cell cycle blocker, inhibits early amplification of duck hepatitis B virus covalently closed circular DNA after in vitro infection of duck hepatocytes.

Authors:  F Turin; C Borel; M Benchaib; A Kay; C Jamard; C Guguen-Guillouzo; C Trépo; O Hantz
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

5.  Lack of effect of antiviral therapy in nondividing hepatocyte cultures on the closed circular DNA of woodchuck hepatitis virus.

Authors:  G Moraleda; J Saputelli; C E Aldrich; D Averett; L Condreay; W S Mason
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

6.  Complement-mediated cytotoxicity and inhibition of ligand binding to hepatocytes by woodchuck hepatitis virus-induced autoantibodies to asialoglycoprotein receptor.

Authors:  J Diao; N D Churchill; T I Michalak
Journal:  Hepatology       Date:  1998-06       Impact factor: 17.425

7.  Detection and sequence analysis of hepatitis B virus integration in peripheral blood mononuclear cells.

Authors:  T Laskus; M Radkowski; L F Wang; M Nowicki; J Rakela
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

8.  Liver transplantation for chronic viral liver disease.

Authors:  A Colantoni; T Hassanein; R Idilman; D H Van Thiel
Journal:  Hepatogastroenterology       Date:  1998 Sep-Oct

9.  The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response.

Authors:  B Rehermann; C Ferrari; C Pasquinelli; F V Chisari
Journal:  Nat Med       Date:  1996-10       Impact factor: 53.440

10.  Identification of woodchuck class I MHC antigens using monoclonal antibodies.

Authors:  T I Michalak; N D Churchill; D Codner; S Drover; W H Marshall
Journal:  Tissue Antigens       Date:  1995-05
View more
  15 in total

Review 1.  The woodchuck as an animal model for pathogenesis and therapy of chronic hepatitis B virus infection.

Authors:  Stephan Menne; Paul J Cote
Journal:  World J Gastroenterol       Date:  2007-01-07       Impact factor: 5.742

2.  Profound antiviral effect of oral administration of MIV-210 on chronic hepadnaviral infection in a woodchuck model of hepatitis B.

Authors:  Tomasz I Michalak; Hong Zhang; Norma D Churchill; Torbjörn Larsson; Nils-Gunnar Johansson; Bo Oberg
Journal:  Antimicrob Agents Chemother       Date:  2009-06-29       Impact factor: 5.191

3.  Molecular characterization of intrahepatic and extrahepatic hepatitis B virus (HBV) reservoirs in patients on suppressive antiviral therapy.

Authors:  C S Coffin; P M Mulrooney-Cousins; M G Peters; G van Marle; J P Roberts; T I Michalak; N A Terrault
Journal:  J Viral Hepat       Date:  2011-06       Impact factor: 3.728

4.  Inhibition by woodchuck hepatitis virus of class I major histocompatibility complex presentation on hepatocytes is mediated by virus envelope pre-S2 protein and can be reversed by treatment with gamma interferon.

Authors:  Jinguo Wang; Tomasz I Michalak
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

5.  Bicistronic woodchuck hepatitis virus core and gamma interferon DNA vaccine can protect from hepatitis but does not elicit sterilizing antiviral immunity.

Authors:  Jinguo Wang; Shashi A Gujar; Lucyna Cova; Tomasz I Michalak
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

6.  Hepatitis C virus persistence after spontaneous or treatment-induced resolution of hepatitis C.

Authors:  Tram N Q Pham; Sonya A MacParland; Patricia M Mulrooney; Helen Cooksley; Nikolai V Naoumov; Tomasz I Michalak
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

7.  Intrahepatic expression of genes affiliated with innate and adaptive immune responses immediately after invasion and during acute infection with woodchuck hepadnavirus.

Authors:  Clifford S Guy; Patricia M Mulrooney-Cousins; Norma D Churchill; Tomasz I Michalak
Journal:  J Virol       Date:  2008-07-02       Impact factor: 5.103

8.  Repeated passage of wild-type woodchuck hepatitis virus in lymphoid cells does not generate cell type-specific variants or alter virus infectivity.

Authors:  Patricia M Mulrooney-Cousins; Tomasz I Michalak
Journal:  J Virol       Date:  2008-05-21       Impact factor: 5.103

9.  Low doses of hepadnavirus induce infection of the lymphatic system that does not engage the liver.

Authors:  Tomasz I Michalak; Patricia M Mulrooney; Carla S Coffin
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

10.  Quantitative detection of hepadnavirus-infected lymphoid cells by in situ PCR combined with flow cytometry: implications for the study of occult virus persistence.

Authors:  Patricia M Mulrooney; Tomasz I Michalak
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.